Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.51 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30053700 | 0.92 | MME (0.50) | MMEOPRM1OPRD1GNPATBACE1 | |
| SCHEMBL31215110 | 0.92 | OPRM1 (0.56) | MMEOPRM1OPRD1GNPATBACE1 | |
| SCHEMBL31199044 | 0.92 | MME (0.59) | MMECTRB1GNPATALDH1A1THRB | |
| SCHEMBL31199046 | 0.89 | MME (0.61) | MMECTRB1OPRM1OPRD1GNPAT | |
| SCHEMBL30055181 | 0.89 | MME (0.49) | MMEOPRM1OPRD1GNPATBACE1 | |
| SCHEMBL29386466 | 0.88 | MME (0.53) | MMEOPRM1OPRD1BACE1 | |
| SCHEMBL30799461 | 0.87 | MME (0.54) | MMECTRB1OPRM1OPRD1GNPAT | |
| SCHEMBL29576197 | 0.86 | MME (0.57) | MMECTRB1ALDH1A1THRBCYP2C9 | |
| SCHEMBL29531699 | 0.86 | MME (0.57) | MMECTRB1ALDH1A1THRBCYP2C9 | |
| SCHEMBL30439482 | 0.86 | OPRM1 (0.48) | OPRM1OPRD1GNPATBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | BOEHRINGER INGELHEIM INT GMH (DE) | 2025-12-18 | — | — | US | claimed |
| EP-3973667-B1 | NETWORK TOPOLOGY DISCOVERY IN SUBSTATION | ABB SCHWEIZ AG (CH) | 2025-05-14 | — | — | EP | claimed |
| CN-117430768-A | Molecularly imprinted flexible covalent organic framework material and preparation method and application thereof | 江南大学 | 2024-01-23 | — | — | CN | claimed |
| CN-116489741-B | Cross-layer energy saving method and system for wireless sensor network | 南昌大学 | 2023-09-01 | — | — | CN | claimed |
| CN-116489741-A | Cross-layer energy saving method and system for wireless sensor network | 南昌大学 | 2023-07-25 | — | — | CN | claimed |
| US-12622762-B2 | Detecting collisions in a robotic surgical system | STRYKER CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4719400-A1 | ORAL PHARMACEUTICAL COMPOSITION OF ISAVUCONAZONIUM OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Zenara Pharma Private Limited (IN) | 2026-04-08 | — | — | EP | disclosed |
| US-12596341-B2 | Operation loop formation for adaptive power grid management | GE VERNOVA INFRASTRUCTURE TECHNOLOGY LLC (US) | 2026-04-07 | — | — | US | disclosed |
| US-12585235-B2 | Data management for adaptive power grid management | GE VERNOVA INFRASTRUCTURE TECHNOLOGY LLC (US) | 2026-03-24 | — | — | US | disclosed |
| US-12570913-B1 | Waste-based additive for solid fuel and related methods | ROUSE ENERGY ENTERPRISES LLC (US) | 2026-03-10 | — | — | US | disclosed |
| CN-121573932-A | Multimeric composite ant cavity material and preparation method thereof | 河南省水利科技应用中心 | 2026-02-27 | — | — | CN | disclosed |
| US-20260047906-A1 | Robotic Surgical System And Method With Dynamic Feed Rate Control Based On Sensed Tissue Transition | STRYKER CORPORATION (US) | 2026-02-19 | — | — | US | disclosed |
| CN-114553858-A | Resource pre-downloading method, device and equipment | 支付宝(杭州)信息技术有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220135892-A1 | SANDWICH GASIFICATION PROCESS FOR HIGH-EFFICIENCY CONVERSION OF CARBONACEOUS FUELS TO CLEAN SYNGAS WITH ZERO RESIDUAL CARBON DISCHARGE | PATEL NIKHIL MANUBHAI (US) | 2022-05-05 | — | — | US | disclosed |
| EP-2973829-B1 | SOLID OXIDE FUEL CELL BUNDLES WITH FLEXIBLE POWER TRANSMISSION SYSTEM | WATT Fuel Cell Corp (US) | 2022-05-04 | — | — | EP | disclosed |
| US-20220110902-A1 | Methods of treating amyloid-beta peptide diseases | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2022-04-14 | — | — | US | disclosed |
| CN-114124518-A | Resource transfer method, device and system and Internet of things equipment | 支付宝(杭州)信息技术有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20220047346-A1 | Robotic System And Method For Removing A Volume Of Material From A Patient | STRYKER CORPORATION (US) | 2022-02-17 | — | — | US | disclosed |
| CN-114041201-A | System and method for multi-stage pulsing in RF plasma tools | 朗姆研究公司 | 2022-02-11 | — | — | CN | disclosed |
| WO-2022023289-A1 | INFRASTRUCTURE EQUIPMENT, COMMUNICATIONS DEVICES AND METHODS | Sony Group Corporation (JP) | 2022-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570913-B1 | Waste-based additive for solid fuel and related methods | SCO2, HAO2, SOD1 | MME 4021/4885CTRB1 4288/4885OPRM1 4301/4885 |
| US-12596341-B2 | Operation loop formation for adaptive power grid management | MDM2, COG4, SMG1 | MME 3734/4885CTRB1 2201/4885OPRM1 3976/4885 |
| US-12585235-B2 | Data management for adaptive power grid management | TP53RK, GEMIN4, RAPGEF4 | MME 4861/4885CTRB1 4846/4885OPRM1 1220/4885 |
| US-20250382344-A1 | Soluble GLP1/GIP/NPY2 Receptor Triple Agonists | GLP1R, GIPR, NPY1R | MME 967/4885CTRB1 1027/4885OPRM1 891/4885 |
| US-12622762-B2 | Detecting collisions in a robotic surgical system | ADAMTS4, ADAMTS1, ADAMTS12 | MME 3675/4885CTRB1 3421/4885OPRM1 1525/4885 |
| US-20260047906-A1 | Robotic Surgical System And Method With Dynamic Feed Rate Control Based On Sensed Tissue Transition | RPTOR, BMP2, BMP4 | MME 986/4885CTRB1 855/4885OPRM1 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.